Onconetix, Inc. (ONCO)
0.4788
-0.07
(-12.63%)
USD |
NASDAQ |
Oct 16, 16:00
0.5301
+0.05
(+10.71%)
After-Hours: 20:00
Onconetix Gross Profit Margin (Quarterly) : 25.15% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.15% |
| March 31, 2026 | -7.91% |
| December 31, 2025 | 81.59% |
| September 30, 2025 | 88.54% |
| June 30, 2025 | 66.20% |
| March 31, 2025 | 45.08% |
| Date | Value |
|---|---|
| December 31, 2024 | 75.94% |
| September 30, 2024 | 18.53% |
| June 30, 2024 | 10.03% |
| March 31, 2024 | 22.56% |
| December 31, 2023 | -1.94K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | 86.65% |
| BridgeBio Pharma, Inc. | 93.68% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.5% |
| Return on Assets | -53.67% |
| Return on Invested Capital | -84.74% |
| Profit Margin (Quarterly) | -16.77K% |
| Operating Margin (Quarterly) | -13.13K% |
| Return on Net Operating Assets | -65.46% |